MA52794A - Nouvelle utilisation pharmaceutique - Google Patents
Nouvelle utilisation pharmaceutiqueInfo
- Publication number
- MA52794A MA52794A MA052794A MA52794A MA52794A MA 52794 A MA52794 A MA 52794A MA 052794 A MA052794 A MA 052794A MA 52794 A MA52794 A MA 52794A MA 52794 A MA52794 A MA 52794A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical use
- new pharmaceutical
- new
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018088701 | 2018-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52794A true MA52794A (fr) | 2021-04-14 |
Family
ID=68697381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052794A MA52794A (fr) | 2018-05-28 | 2019-05-27 | Nouvelle utilisation pharmaceutique |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210196783A1 (fr) |
EP (1) | EP3802562A4 (fr) |
JP (1) | JP2021525242A (fr) |
KR (1) | KR20210016365A (fr) |
CN (1) | CN112236440A (fr) |
MA (1) | MA52794A (fr) |
TW (1) | TW202016127A (fr) |
WO (1) | WO2019228307A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019007356A1 (fr) * | 2017-07-05 | 2019-01-10 | Jiangyin Usun Pharmaceutical Co., Ltd. | Formulations topiques comprenant du montélukast et combinaisons avec protéines d'adhérence de moule |
JP2022516729A (ja) * | 2019-01-10 | 2022-03-02 | ジャンイン ムコケア ファーマシューティカル カンパニー,リミテッド | ロイコトリエン受容体アンタゴニストを含有する新たな製剤 |
WO2021047648A1 (fr) * | 2019-09-14 | 2021-03-18 | Jiangyin Usun Pharmaceutical Co., Ltd. | Nouveaux peptides |
KR20220116468A (ko) * | 2019-12-02 | 2022-08-23 | 엔리티사 (상하이) 파마슈티컬 컴퍼니 리미티드 | 펩티드 및 다당류의 새로운 접합체 |
US20230372324A1 (en) * | 2020-10-13 | 2023-11-23 | Diomed Developments Ltd. | Gel formulations comprising montelukast |
WO2022193186A1 (fr) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | Nouveaux agents diagnostiques et thérapeutiques |
US20240165247A1 (en) * | 2021-03-17 | 2024-05-23 | Jiangyin Usun Pharmaceutical Co., Ltd. | New peptide conjugates |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6100296A (en) * | 1995-06-06 | 1996-12-24 | Hemosphere, Inc. | Protein particles for therapeutic and diagnostic use |
US7098305B2 (en) * | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
KR20070121669A (ko) * | 2005-02-16 | 2007-12-27 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | 뼈 상태 치료 또는 예방을 위한 약제학적 조성물 |
EP2101547B1 (fr) * | 2008-03-11 | 2014-03-05 | Vita Zahnfabrik H. Rauter GmbH & Co. KG | Four de frittage dentaire et procédé de frittage d'éléments dentaires céramiques |
JP2012526155A (ja) * | 2009-08-25 | 2012-10-25 | ポステック アカデミー−インダストリー ファンデーション | イガイ接着蛋白質またはその変異体に陰イオン性高分子が含まれたコアセルベート |
KR20150014483A (ko) * | 2012-05-11 | 2015-02-06 | 주식회사 카엘젬백스 | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 |
CN105392468A (zh) * | 2013-05-20 | 2016-03-09 | 高敏 | 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用 |
US10568938B2 (en) * | 2015-07-20 | 2020-02-25 | Jiangyin Bengt I. Samuelsson Institute Of Life Science Co., Ltd. | Mussel adhesive protein product and applications thereof in suppression of skin inflammations |
WO2017028025A1 (fr) * | 2015-08-14 | 2017-02-23 | 江阴市本特塞缪森生命科学研究院有限公司 | Produit de protéine adhésive de moule et son utilisation servant à inhiber l'inflammation d'une muqueuse |
WO2017181372A1 (fr) * | 2016-04-20 | 2017-10-26 | 江阴市本特塞缪森生命科学研究院有限公司 | Produit de protéine adhésive de moule et son utilisation pour inhiber une inflammation vasculaire |
CN106581656A (zh) * | 2016-12-30 | 2017-04-26 | 江阴贝瑞森生化技术有限公司 | 一种用于小儿舌舔皮炎的软膏 |
WO2019011286A1 (fr) * | 2017-07-14 | 2019-01-17 | Jiangyin Usun Pharmaceutical Co., Ltd. | Utilisation antivirale de protéines adhésives de moule |
-
2019
- 2019-05-27 MA MA052794A patent/MA52794A/fr unknown
- 2019-05-27 JP JP2020565331A patent/JP2021525242A/ja active Pending
- 2019-05-27 EP EP19810206.3A patent/EP3802562A4/fr active Pending
- 2019-05-27 US US17/058,482 patent/US20210196783A1/en not_active Abandoned
- 2019-05-27 WO PCT/CN2019/088593 patent/WO2019228307A1/fr unknown
- 2019-05-27 KR KR1020207034257A patent/KR20210016365A/ko unknown
- 2019-05-27 CN CN201980036092.XA patent/CN112236440A/zh active Pending
- 2019-05-28 TW TW108118376A patent/TW202016127A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021525242A (ja) | 2021-09-24 |
EP3802562A1 (fr) | 2021-04-14 |
WO2019228307A1 (fr) | 2019-12-05 |
KR20210016365A (ko) | 2021-02-15 |
EP3802562A4 (fr) | 2022-06-01 |
TW202016127A (zh) | 2020-05-01 |
US20210196783A1 (en) | 2021-07-01 |
CN112236440A (zh) | 2021-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52794A (fr) | Nouvelle utilisation pharmaceutique | |
CA188843S (fr) | Bague | |
CA188929S (fr) | Bague | |
MA45613A (fr) | Composés polycycliques-carbamoylpyridones et leur utilisation pharmaceutique | |
DK3743406T3 (da) | Tmem16a modulatorer | |
DE112019001333A5 (de) | Einzelner gerüststiel | |
DK3724165T3 (da) | Nye benzamidderivater som PPAR-gamma-modulatorer | |
MA43705A (fr) | Formulation pharmaceutique | |
DK3687261T3 (da) | Elektrostatisk afladningsindretning | |
DK3920890T3 (da) | Oral cannabinoid-tablet | |
DE112019001116B8 (de) | Flüssigkeitsabscheider | |
MA49822A (fr) | Combinaison pharmaceutique comprenant du ponesimod | |
MA48983A (fr) | Nouvelle utilisation thérapeutique de ligands h3 | |
MA55016A (fr) | Utilisation du spiropidion | |
MA45855A (fr) | Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide | |
JP1717133S (ja) | コンピュータ | |
UA39602S (uk) | Комплект етикеток | |
UA38661S (uk) | Комплект етикеток | |
UA39416S (uk) | Комплект етикеток | |
UA38480S (uk) | Комплект етикеток | |
UA37769S (uk) | Комплект етикеток | |
UA37659S (uk) | Комплект етикеток | |
UA37658S (uk) | Комплект етикеток | |
JP1640701S (ja) | シザーケース | |
UA37322S (uk) | Комплект етикеток |